메뉴 건너뛰기




Volumn 19, Issue 10, 2002, Pages 793-805

Health-related quality of life and long-term therapy with pravastatin and tocopherol (vitamin E) in older adults

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MUSCLE ENZYME; PLACEBO; PRAVASTATIN; STATIN; ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TOCOPHEROL; TRIACYLGLYCEROL;

EID: 0036417357     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200219100-00008     Document Type: Article
Times cited : (34)

References (56)
  • 1
    • 0030967498 scopus 로고    scopus 로고
    • Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons
    • Corti MC, Guralnik JM, Salive ME, et al. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med 1997; 126: 753-60
    • (1997) Ann Intern Med , vol.126 , pp. 753-760
    • Corti, M.C.1    Guralnik, J.M.2    Salive, M.E.3
  • 2
    • 0025695497 scopus 로고
    • High blood cholesterol in elderly men and the excess risk for coronary heart disease
    • Rubin SM, Sidney S, Black DM, et al. High blood cholesterol in elderly men and the excess risk for coronary heart disease. Ann Intern Med 1990; 113: 916-20
    • (1990) Ann Intern Med , vol.113 , pp. 916-920
    • Rubin, S.M.1    Sidney, S.2    Black, D.M.3
  • 3
    • 0035897938 scopus 로고    scopus 로고
    • Midlife vascular risk factors and Alzheimer' s disease in later life: Longitudinal, population based study
    • Kivipelto M, Helkala EL, Laakso MP, et al. Midlife vascular risk factors and Alzheimer' s disease in later life: Longitudinal, population based study. BMJ 2001; 322: 1447-51
    • (2001) BMJ , vol.322 , pp. 1447-1451
    • Kivipelto, M.1    Helkala, E.L.2    Laakso, M.P.3
  • 4
    • 0031976318 scopus 로고    scopus 로고
    • Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease
    • Notkola IL, Sulkava R, Pekkanen J, et al. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 1998; 17: 14-20
    • (1998) Neuroepidemiology , vol.17 , pp. 14-20
    • Notkola, I.L.1    Sulkava, R.2    Pekkanen, J.3
  • 5
    • 0029072551 scopus 로고
    • Interactions of apolipoprotein E genotype, total cholesterol level, age and sex in prediction of Alzheimer's disease: A case-control study
    • Jarvik GP, Wijsman EM, Kukull WA, et al. Interactions of apolipoprotein E genotype, total cholesterol level, age and sex in prediction of Alzheimer's disease: A case-control study. Neurology 1995; 45: 1092-6
    • (1995) Neurology , vol.45 , pp. 1092-1096
    • Jarvik, G.P.1    Wijsman, E.M.2    Kukull, W.A.3
  • 6
    • 0025695497 scopus 로고
    • High blood cholesterol in elderly men and the excess risk for coronary heart disease
    • Rubin SM, Sidney S, Black DM, et al. High blood cholesterol in elderly men and the excess risk for coronary heart disease. Ann Intern Med 1990; 113: 916-20
    • (1990) Ann Intern Med , vol.113 , pp. 916-920
    • Rubin, S.M.1    Sidney, S.2    Black, D.M.3
  • 7
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin survival study (4S)
    • Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin survival study (4S). Lancet 1994; 344: 1383-9
    • (1994) Lancet , vol.344 , pp. 1383-1389
  • 8
    • 0342981862 scopus 로고    scopus 로고
    • The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
    • Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001-9
    • (1996) N Engl J Med , vol.335 , pp. 1001-1009
    • Sacks, F.M.1    Pfeffer, M.A.2    Moye, L.A.3
  • 9
    • 0344653659 scopus 로고    scopus 로고
    • Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: Findings from the Scandinavian Simvastatin survival study (4S)
    • Miettinen TA, Pyörälä K, Olsson AG, et al. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: Findings from the Scandinavian Simvastatin survival study (4S). Circulation 1997; 96: 4211-8
    • (1997) Circulation , vol.96 , pp. 4211-4218
    • Miettinen, T.A.1    Pyörälä, K.2    Olsson, A.G.3
  • 10
    • 14444271787 scopus 로고    scopus 로고
    • Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range
    • Lewis SJ, Moye LA, Sacks FM, et al. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Ann Intern Med 1998; 129: 681-9
    • (1998) Ann Intern Med , vol.129 , pp. 681-689
    • Lewis, S.J.1    Moye, L.A.2    Sacks, F.M.3
  • 11
    • 0035873251 scopus 로고    scopus 로고
    • Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID Trial
    • Hunt D, Young P, Simes J, et al. Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID Trial. Ann Intern Med 2001; 134: 931-40
    • (2001) Ann Intern Med , vol.134 , pp. 931-940
    • Hunt, D.1    Young, P.2    Simes, J.3
  • 13
    • 0037031061 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: A randomised placebo-controlled trial
    • Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: A randomised placebo-controlled trial. Lancet 2002; 360: 7-22
    • (2002) Lancet , vol.360 , pp. 7-22
  • 14
    • 0034638746 scopus 로고    scopus 로고
    • Statins and the risk of dementia
    • Jick H, Zornberg GL, Jick SS, et al. Statins and the risk of dementia. Lancet 2000; 356: 1627-31
    • (2000) Lancet , vol.356 , pp. 1627-1631
    • Jick, H.1    Zornberg, G.L.2    Jick, S.S.3
  • 15
    • 0033772113 scopus 로고    scopus 로고
    • Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors
    • Wolozin B, Kellman W, Ruosseau P, et al. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 2000; 57: 1439-43
    • (2000) Arch Neurol , vol.57 , pp. 1439-1443
    • Wolozin, B.1    Kellman, W.2    Ruosseau, P.3
  • 16
    • 0032496637 scopus 로고    scopus 로고
    • Primary care practice adherence to national cholesterol education program guidelines for patients with coronary heart disease
    • McBride P, Schrott HG, Plane MB, et al. Primary care practice adherence to national cholesterol education program guidelines for patients with coronary heart disease. Arch Intern Med 1998: 158: 1238-44
    • (1998) Arch Intern Med , vol.158 , pp. 1238-1244
    • McBride, P.1    Schrott, H.G.2    Plane, M.B.3
  • 17
    • 0031711522 scopus 로고    scopus 로고
    • Underutilization of lipid-lowering drugs in older persons with prior myocardial infarction and a serum low-density lipoprotein cholesterol >125 mg/dl
    • Aronow WS. Underutilization of lipid-lowering drugs in older persons with prior myocardial infarction and a serum low-density lipoprotein cholesterol >125 mg/dl. Am J Cardiol 1998; 82: 668-9
    • (1998) Am J Cardiol , vol.82 , pp. 668-669
    • Aronow, W.S.1
  • 18
    • 0031696850 scopus 로고    scopus 로고
    • Underutilization of measurement of serum low-density lipoprotein cholesterol levels and of lipid-lowering therapy in older patients with manifest atherosclerotic disease
    • Mendelson G, Aronow WS. Underutilization of measurement of serum low-density lipoprotein cholesterol levels and of lipid-lowering therapy in older patients with manifest atherosclerotic disease. J Am Geriatr Soc 1998; 46: 1128-31
    • (1998) J Am Geriatr Soc , vol.46 , pp. 1128-1131
    • Mendelson, G.1    Aronow, W.S.2
  • 19
    • 0033434058 scopus 로고    scopus 로고
    • Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease
    • Majumdar SR, Gurwitz JH, Soumerai SB. Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease. J Gen Intern Med 1999; 14: 711-7
    • (1999) J Gen Intern Med , vol.14 , pp. 711-717
    • Majumdar, S.R.1    Gurwitz, J.H.2    Soumerai, S.B.3
  • 20
    • 0034723758 scopus 로고    scopus 로고
    • The lipid treatment assessment project (L-TAP): A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals
    • Pearson TA, Laurora I, Chu H, et al. The lipid treatment assessment project (L-TAP): A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 2000; 160: 459-67
    • (2000) Arch Intern Med , vol.160 , pp. 459-467
    • Pearson, T.A.1    Laurora, I.2    Chu, H.3
  • 21
    • 0035830405 scopus 로고    scopus 로고
    • Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: Data from the national registry of myocardial infarction 3
    • Fonarow GC, French WJ, Parsons LS, et al. Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: Data from the national registry of myocardial infarction 3. Circulation 2001; 103: 38-44
    • (2001) Circulation , vol.103 , pp. 38-44
    • Fonarow, G.C.1    French, W.J.2    Parsons, L.S.3
  • 22
    • 0028282508 scopus 로고
    • Efficacy and safety of pravastatin in the long-term treatment of elderly patients with hypercholesterolemia
    • Santinga JT, Rosman HS, Rubenfire M, et al. Efficacy and safety of pravastatin in the long-term treatment of elderly patients with hypercholesterolemia. Am J Med 1994; 96: 509-15
    • (1994) Am J Med , vol.96 , pp. 509-515
    • Santinga, J.T.1    Rosman, H.S.2    Rubenfire, M.3
  • 23
    • 0028880638 scopus 로고
    • The effectiveness and safety of low dose pravastatin in elderly hypertensive hypercholesterolemic subjects on antihypertensive therapy
    • Chan P, Lee C, Lin TS, et al. The effectiveness and safety of low dose pravastatin in elderly hypertensive hypercholesterolemic subjects on antihypertensive therapy. Am J Hypertens 1995; 8: 1099-104
    • (1995) Am J Hypertens , vol.8 , pp. 1099-1104
    • Chan, P.1    Lee, C.2    Lin, T.S.3
  • 24
    • 0032559785 scopus 로고    scopus 로고
    • An overview of the clinical safety profile of atorvastatin (Lipitor), a new HMG-CoA reductase inhibitor
    • Black DM, Bakker-Arkema RG, Nawrocki JW. An overview of the clinical safety profile of atorvastatin (Lipitor), a new HMG-CoA reductase inhibitor. Arch Intern Med 1998; 158: 577-84
    • (1998) Arch Intern Med , vol.158 , pp. 577-584
    • Black, D.M.1    Bakker-Arkema, R.G.2    Nawrocki, J.W.3
  • 25
    • 0031021211 scopus 로고    scopus 로고
    • Effect of pharmacologic lipid lowering on health-related quality of life in older persons: Results from the Cholesterol Reduction in Seniors Program (CRISP) pilot study
    • Santanello NC, Barber BL, Applegate WB, et al., for the CRISP Collaborative Study Group. Effect of pharmacologic lipid lowering on health-related quality of life in older persons: Results from the Cholesterol Reduction in Seniors Program (CRISP) pilot study. J Am Geriatr Soc 1997; 45: 8-14
    • (1997) J Am Geriatr Soc , vol.45 , pp. 8-14
    • Santanello, N.C.1    Barber, B.L.2    Applegate, W.B.3
  • 26
    • 0026651406 scopus 로고
    • Decline in cognitive performance in aging twins: Heritability and biobehavioral predictors from the national heart, lung and blood institute twin study
    • Swan GE, LaRue A, Carmelli D, et al. Decline in cognitive performance in aging twins: Heritability and biobehavioral predictors from the national heart, lung and blood institute twin study. Arch Neurol 1992; 49: 476-81
    • (1992) Arch Neurol , vol.49 , pp. 476-481
    • Swan, G.E.1    LaRue, A.2    Carmelli, D.3
  • 27
    • 0028814270 scopus 로고
    • Do low cholesterol levels slow mental processing?
    • Benton D. Do low cholesterol levels slow mental processing? Psychosom Med 1995; 57: 50-3
    • (1995) Psychosom Med , vol.57 , pp. 50-53
    • Benton, D.1
  • 28
    • 0030690043 scopus 로고    scopus 로고
    • Factors associated with cognitive impairment among older Italian inpatients
    • Gruppo Italiano di Farmacovigilanza nell'Anziano (G.I.F.A.)
    • Cattin L, Bordin P, Fonda M, et al. Factors associated with cognitive impairment among older Italian inpatients. Gruppo Italiano di Farmacovigilanza nell'Anziano (G.I.F.A.). J Am Geriatr Soc 1997; 45: 1324-30
    • (1997) J Am Geriatr Soc , vol.45 , pp. 1324-1330
    • Cattin, L.1    Bordin, P.2    Fonda, M.3
  • 29
    • 0027472876 scopus 로고
    • Plasma cholesterol and depressive symptoms in older men
    • Morgan RE, Palinkas LA, Barrett-Connor EL, et al. Plasma cholesterol and depressive symptoms in older men. Lancet 1993; 341: 75-9
    • (1993) Lancet , vol.341 , pp. 75-79
    • Morgan, R.E.1    Palinkas, L.A.2    Barrett-Connor, E.L.3
  • 30
    • 0030561115 scopus 로고    scopus 로고
    • Serum lipid concentrations in patients with major depressive disorder
    • Olusi SO, Fido AA. Serum lipid concentrations in patients with major depressive disorder. Biol Psychiatry 1996; 40: 1128-31
    • (1996) Biol Psychiatry , vol.40 , pp. 1128-1131
    • Olusi, S.O.1    Fido, A.A.2
  • 31
    • 0030740364 scopus 로고    scopus 로고
    • Serum cholesterol and intellectual performance
    • Muldoon MF, Ryan CM, Matthews KA, et al. Serum cholesterol and intellectual performance. Psychosom Med 1997; 59: 382-7
    • (1997) Psychosom Med , vol.59 , pp. 382-387
    • Muldoon, M.F.1    Ryan, C.M.2    Matthews, K.A.3
  • 32
    • 0034015649 scopus 로고    scopus 로고
    • Effects of lovastatin on cognitive function and psychological well-being
    • Muldoon MF, Barger SD, Ryan CM, et al. Effects of lovastatin on cognitive function and psychological well-being. Am J Med 2000; 108: 538-46
    • (2000) Am J Med , vol.108 , pp. 538-546
    • Muldoon, M.F.1    Barger, S.D.2    Ryan, C.M.3
  • 33
    • 0026329744 scopus 로고
    • Effects of lovastatin and pravastatin on sleep efficiency and sleep stages
    • Vgontzas AN, Kales A, Bixler EO, et al. Effects of lovastatin and pravastatin on sleep efficiency and sleep stages. Clin Pharmacol Ther 1991; 50: 730-7
    • (1991) Clin Pharmacol Ther , vol.50 , pp. 730-737
    • Vgontzas, A.N.1    Kales, A.2    Bixler, E.O.3
  • 34
    • 0027358626 scopus 로고
    • Lovastatin-associated sleep and mood disturbances
    • Rosenson RS, Goranson NL. Lovastatin-associated sleep and mood disturbances. Am J Med 1993; 95: 548-9
    • (1993) Am J Med , vol.95 , pp. 548-549
    • Rosenson, R.S.1    Goranson, N.L.2
  • 35
    • 0026740298 scopus 로고
    • Comparative effects of pravastatin and lovastatin on nighttime sleep and daytime performance
    • Roth T, Richardson GR, Sullivan JP, et al. Comparative effects of pravastatin and lovastatin on nighttime sleep and daytime performance. Clin Cardiol 1992; 15: 426-32
    • (1992) Clin Cardiol , vol.15 , pp. 426-432
    • Roth, T.1    Richardson, G.R.2    Sullivan, J.P.3
  • 36
    • 0032411661 scopus 로고    scopus 로고
    • Supplement users differ from nonusers in demographic, lifestyle, dietary and health characteristics
    • Lyle BJ, Mares-Perlman JA, Klein BEK, et al. Supplement users differ from nonusers in demographic, lifestyle, dietary and health characteristics. J Nutr 1998; 128: 2355-62
    • (1998) J Nutr , vol.128 , pp. 2355-2362
    • Lyle, B.J.1    Mares-Perlman, J.A.2    Klein, B.E.K.3
  • 38
    • 0034688195 scopus 로고    scopus 로고
    • Vitamin E supplementation and cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators
    • Yusuf S, Dagenais G, Pogue J, et al. Vitamin E supplementation and cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N Engl J Med 2000; 342 (3): 154-60
    • (2000) N Engl J Med , vol.342 , Issue.3 , pp. 154-160
    • Yusuf, S.1    Dagenais, G.2    Pogue, J.3
  • 39
    • 0026769612 scopus 로고
    • Tolerance and safety of vitamin E: A toxicological position report
    • Kappus H, Diplock AT. Tolerance and safety of vitamin E: A toxicological position report. Free Radic Biol Med 1992; 13: 55-74
    • (1992) Free Radic Biol Med , vol.13 , pp. 55-74
    • Kappus, H.1    Diplock, A.T.2
  • 40
    • 0035140261 scopus 로고    scopus 로고
    • A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure
    • Keith ME, Jeejeebhoy KN, Langer A, et al. A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure. Am J Clin Nutr 2001; 73 (2): 219-24
    • (2001) Am J Clin Nutr , vol.73 , Issue.2 , pp. 219-224
    • Keith, M.E.1    Jeejeebhoy, K.N.2    Langer, A.3
  • 41
    • 0030967165 scopus 로고    scopus 로고
    • A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's disease cooperative study
    • Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's disease cooperative study. N Engl J Med 1997; 336 (17): 1216-22
    • (1997) N Engl J Med , vol.336 , Issue.17 , pp. 1216-1222
    • Sano, M.1    Ernesto, C.2    Thomas, R.G.3
  • 42
    • 0034800655 scopus 로고    scopus 로고
    • A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8
    • Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001; 119 (10): 1417-36
    • (2001) Arch Ophthalmol , vol.119 , Issue.10 , pp. 1417-1436
  • 43
    • 0035199773 scopus 로고    scopus 로고
    • The effects of lipid-lowering and antioxidant vitamin therapies on flow-mediated vasodilation of the brachial artery in older adults with hypercholesterolemia
    • Stein JH, Carlsson CM, Papcke-Benson K, et al. The effects of lipid-lowering and antioxidant vitamin therapies on flow-mediated vasodilation of the brachial artery in older adults with hypercholesterolemia. J Am Coll Cardiol 2001; 38: 1806-13
    • (2001) J Am Coll Cardiol , vol.38 , pp. 1806-1813
    • Stein, J.H.1    Carlsson, C.M.2    Papcke-Benson, K.3
  • 44
    • 0015348189 scopus 로고
    • Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
    • Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
    • (1972) Clin Chem , vol.18 , pp. 499-502
    • Friedewald, W.T.1    Levy, R.I.2    Fredrickson, D.S.3
  • 45
    • 33847516233 scopus 로고
    • Developing measures of perceived life quality: Results from several national surveys
    • Andrews FM, Withey SB. Developing measures of perceived life quality: Results from several national surveys. Social Indicators Research 1974; 1: 1-26
    • (1974) Social Indicators Research , vol.1 , pp. 1-26
    • Andrews, F.M.1    Withey, S.B.2
  • 46
    • 0020286558 scopus 로고
    • Development and validation of a geriatric depression screening scale: A preliminary report
    • Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 1983; 17: 37-49
    • (1983) J Psychiatr Res , vol.17 , pp. 37-49
    • Yesavage, J.A.1    Brink, T.L.2    Rose, T.L.3
  • 47
    • 0025980516 scopus 로고
    • Development and testing of the assessment of living skills and resources (ALSAR) in elderly community-dwelling veterans
    • Williams JH, Drinka TJ, Greenberg JR, et al. Development and testing of the assessment of living skills and resources (ALSAR) in elderly community-dwelling veterans. Gerontologist 1991; 31: 84-91
    • (1991) Gerontologist , vol.31 , pp. 84-91
    • Williams, J.H.1    Drinka, T.J.2    Greenberg, J.R.3
  • 50
    • 0002344794 scopus 로고
    • Bootstrap methods: Another look at the jackknife
    • Efron B. Bootstrap methods: Another look at the jackknife. Annals of Statistics 1983; 7: 1-26
    • (1983) Annals of Statistics , vol.7 , pp. 1-26
    • Efron, B.1
  • 51
    • 0000357303 scopus 로고
    • Combining dependent tests with incomplete repeated measurements
    • Wei LJ, Johnson WE. Combining dependent tests with incomplete repeated measurements. Biometrika 1985; 72: 359-64
    • (1985) Biometrika , vol.72 , pp. 359-364
    • Wei, L.J.1    Johnson, W.E.2
  • 52
    • 0026320718 scopus 로고
    • Semi-parametric and non-parametric methods for the analysis of repeated measurements with applications to clinical trials
    • Davis CS. Semi-parametric and non-parametric methods for the analysis of repeated measurements with applications to clinical trials. Stat Med 1991; 10: 1959-80
    • (1991) Stat Med , vol.10 , pp. 1959-1980
    • Davis, C.S.1
  • 53
    • 0003406415 scopus 로고    scopus 로고
    • Dallas (TX): American Heart Association
    • American Heart Association 2002. Heart and Stroke Statistical Update. Dallas (TX): American Heart Association, 2001
    • (2001) Heart and Stroke Statistical Update
  • 54
    • 0035640845 scopus 로고    scopus 로고
    • Some practical guidelines for effective sample size determination
    • Lenth RV. Some practical guidelines for effective sample size determination. Am Stat 2001; 55: 187-93
    • (2001) Am Stat , vol.55 , pp. 187-193
    • Lenth, R.V.1
  • 56
    • 0023851627 scopus 로고
    • A scale for the estimation of sleep problems in clinical research
    • Jenkins CD, Stanton BA, Niemcryk SJ, et al. A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol 1988; 41: 313-21
    • (1988) J Clin Epidemiol , vol.41 , pp. 313-321
    • Jenkins, C.D.1    Stanton, B.A.2    Niemcryk, S.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.